News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tatsis Ourania
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,500 shares
@ $355, valued at
$887.5k
|
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 5,750 shares
@ $345.79, valued at
$2M
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,308 shares
@ $289.12, valued at
$956.4k
Sold 283 shares
@ $287.2, valued at
$81.3k
Sold 51 shares
@ $288.33, valued at
$14.7k
Sold 20 shares
@ $289.29, valued at
$5.8k
|
|
| 02/22/2023 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 4,498 shares
@ $292.85, valued at
$1.3M
Sold 4 shares
@ $291.01, valued at
$1.2k
Sold 145 shares
@ $292.85, valued at
$42.5k
Sold 207 shares
@ $293.83, valued at
$60.8k
Sold 124 shares
@ $294.77, valued at
$36.6k
|
|
| 02/14/2023 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 1,377 shares
@ $294.33, valued at
$405.3k
Paid exercise price by delivering 2,995 shares
@ $298.26, valued at
$893.3k
Sold 2 shares
@ $295.84, valued at
$591.7
Sold 78 shares
@ $298.11, valued at
$23.3k
Sold 120 shares
@ $298.98, valued at
$35.9k
Sold 64 shares
@ $299.88, valued at
$19.2k
Sold 11 shares
@ $300.79, valued at
$3.3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 1,036 shares
@ $217.57, valued at
$225.4k
|
|
| 02/19/2021 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,000 shares
@ $211.75, valued at
$423.5k
|
|
| 02/12/2021 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 1,230 shares
@ $214.16, valued at
$263.4k
|
|
| 02/05/2021 |
4
| Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 2,814 shares
@ $0
Granted 6,194 shares
@ $0
Granted 13,952 shares
@ $0 |
|
| 05/19/2020 |
4
| Tatsis Ourania (EVP, Chief Regulatory Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 10 shares
@ $276.35, valued at
$2.8k
Sold 17 shares
@ $279.93, valued at
$4.8k
Sold 21 shares
@ $281.23, valued at
$5.9k
Sold 10 shares
@ $284.3, valued at
$2.8k
Sold 20 shares
@ $286.12, valued at
$5.7k
Sold 33 shares
@ $287.61, valued at
$9.5k
Sold 9 shares
@ $288.38, valued at
$2.6k
|
|
| 05/08/2020 |
4
| Tatsis Ourania (EVP, Chief Regulatory Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 43 shares
@ $268.8, valued at
$11.6k
Sold 136 shares
@ $270.19, valued at
$36.7k
Sold 217 shares
@ $272.09, valued at
$59k
Sold 210 shares
@ $273.15, valued at
$57.4k
Sold 330 shares
@ $274.13, valued at
$90.5k
Sold 30 shares
@ $275.3, valued at
$8.3k
Exercised 559 options to buy
@ $187.53, valued at
$104.8k
Exercised 407 options to buy
@ $155.57, valued at
$63.3k
|
|
| 02/26/2020 |
4
| Tatsis Ourania (SVP, CRO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 1,036 shares
@ $239.23, valued at
$247.8k
Sold 416 shares
@ $229.57, valued at
$95.5k
Sold 160 shares
@ $231.82, valued at
$37.1k
Sold 80 shares
@ $232.43, valued at
$18.6k
Sold 240 shares
@ $234.43, valued at
$56.3k
Sold 160 shares
@ $235.39, valued at
$37.7k
Sold 240 shares
@ $237.81, valued at
$57.1k
|
|
| 02/19/2020 |
4
| Tatsis Ourania (SVP, CRO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 597 shares
@ $241.5, valued at
$144.2k
Sold 160 shares
@ $241.82, valued at
$38.7k
Sold 528 shares
@ $242.78, valued at
$128.2k
Sold 160 shares
@ $243.78, valued at
$39k
Sold 286 shares
@ $244.99, valued at
$70.1k
Sold 145 shares
@ $245.75, valued at
$35.6k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| Tatsis Ourania (SVP, CRO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,675 shares
@ $227.53, valued at
$381.1k
Exercised 1,675 options to buy
@ $187.53, valued at
$314.1k
|
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|